WINDTREE THERAPEUTICS INC /DE/ Contract Liability (Deferred Revenue)
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Contract Liability (Deferred Revenue) of $158.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2019-11-14
- 2019-03-31: Contract with Customer, Liability, Current $158.00K.
- 2018-12-31: Contract with Customer, Liability, Current $198.00K.
- 2018-09-30: Contract with Customer, Liability, Current $503.00K.
- 2017-12-31: Contract with Customer, Liability, Current $884.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2019-03-31 | $158.00K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $198.00K 10-Q · filed 2019-11-14 |
| 2018-09-30 | $503.00K 10-Q · filed 2018-11-14 |
| 2017-12-31 | $884.00K 10-K/A · filed 2019-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |